RCS - IP Group PLC - Life Sciences update event

IPAnnouncement

08/06/2023 09:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230608:nRSH0982Ca&default-theme=true

RNS Number : 0982C  IP Group PLC  08 June 2023

 FOR RELEASE ON  08 June 2023

IP Group - Life Sciences investor update

IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which
invests in breakthrough science and innovation companies with the potential to
create a better future for all, announces that it will hold a life sciences
investor update on Thursday June 15 2023 featuring Dr Gordon Sanghera, CEO of
Oxford Nanopore Technologies plc, and Professor Sir Peter Donnelly, CEO of
portfolio company Genomics.

 

The event will be hosted by CEO Greg Smith and Dr Sam Williams, Managing
Partner of Life Sciences at IP Group, and, as announced on 20 April 2023, will
be followed by the Group's Annual General Meeting at 11am. Further details of
the event and how to register can be found here: bit.ly/3oUjNqb
(https://mailchi.mp/b3613f598d66/ip-group-portfolio-intelligence-20265608) .

 

The update will also be available remotely through the Investor Meet Company
platform. Questions can be submitted in advance of the event via the Investor
Meet Company Platform up to 9am the day before the meeting or at any time
during the live presentation. Investors can sign up to Investor Meet Company
for free via:
https://www.investormeetcompany.com/ip-group-plc/register-investor
(https://www.investormeetcompany.com/ip-group-plc/register-investor) .
Investors who already follow IP Group plc on the Investor Meet Company
platform will automatically be invited.

 

No material new information will be released by the Company during the
presentation.

 

For more information, please contact:

 

 IP Group plc                       www.ipgroupplc.com
 Liz Vaughan-Adams, Communications  +44 (0) 20 7444 0062/+44 (0) 7967 312125
 Portland
 Vic Wallin                         +44 (0) 7973 823119

 Alex Donaldson                     +44 (0) 7516 729702

 

Notes for editors

 

About IP Group

 

IP Group accelerates the impact of science for a better
future. As the most active UK based, early stage science investor, we
develop and support some of the world's most exciting businesses in
deeptech, life sciences and cleantech (led by Kiko Ventures). Through
Parkwalk, the UK's largest growth EIS fund manager, we also back
world-changing innovation emerging in leading universities and research
institutions. Our specialist investment team combines sector expertise with
an international approach. Together we have a strong track record of success,
having backed high-profile companies including Oxford Nanopore Technologies
plc, First Light Fusion, Hysata, and Oxa. IP Group is listed on the Main
Market of the London Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com
(http://www.ipgroupplc.com/) .

 

ENDS

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAUPUBCQUPWUMR